157 related articles for article (PubMed ID: 30977156)
1. Chemokine receptor 3 is a negative regulator of trabecular bone mass in female mice.
Mohan S; Hu Y; Edderkaoui B
J Cell Biochem; 2019 Aug; 120(8):13974-13984. PubMed ID: 30977156
[TBL] [Abstract][Full Text] [Related]
2. CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice.
Rosendahl S; Sulniute R; Eklund M; Koskinen Holm C; Johansson MJO; Kindstedt E; Lindquist S; Lundberg P
J Biol Chem; 2021; 296():100177. PubMed ID: 33303631
[TBL] [Abstract][Full Text] [Related]
3. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
[TBL] [Abstract][Full Text] [Related]
4. Chemokine ligand 28 (CCL28) negatively regulates trabecular bone mass by suppressing osteoblast and osteoclast activities.
Iwamoto R; Takahashi T; Yoshimi K; Imai Y; Koide T; Hara M; Ninomiya T; Nakamura H; Sayama K; Yukita A
J Bone Miner Metab; 2021 Jul; 39(4):558-571. PubMed ID: 33721112
[TBL] [Abstract][Full Text] [Related]
5. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
6. Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice.
Lademann F; Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Heuer H; Rauner M
Thyroid; 2020 Feb; 30(2):329-342. PubMed ID: 31910109
[No Abstract] [Full Text] [Related]
7. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
[TBL] [Abstract][Full Text] [Related]
8. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
[TBL] [Abstract][Full Text] [Related]
9. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
10. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
11. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
12. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.
Hoshino A; Iimura T; Ueha S; Hanada S; Maruoka Y; Mayahara M; Suzuki K; Imai T; Ito M; Manome Y; Yasuhara M; Kirino T; Yamaguchi A; Matsushima K; Yamamoto K
J Biol Chem; 2010 Sep; 285(37):28826-37. PubMed ID: 20571024
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.
Le PT; Bishop KA; Maridas DE; Motyl KJ; Brooks DJ; Nagano K; Baron R; Bouxsein ML; Rosen CJ
Bone; 2017 Dec; 105():103-114. PubMed ID: 28821457
[TBL] [Abstract][Full Text] [Related]
15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
16. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
[TBL] [Abstract][Full Text] [Related]
17. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
[TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
Fader KA; Nault R; Raehtz S; McCabe LR; Zacharewski TR
Toxicol Appl Pharmacol; 2018 Jun; 348():85-98. PubMed ID: 29673856
[TBL] [Abstract][Full Text] [Related]
19. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
Lean JM; Murphy C; Fuller K; Chambers TJ
J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
[TBL] [Abstract][Full Text] [Related]
20. An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.
Maile LA; DeMambro VE; Wai C; Lotinun S; Aday AW; Capps BE; Beamer WG; Rosen CJ; Clemmons DR
J Bone Miner Res; 2011 Sep; 26(9):2068-81. PubMed ID: 21638321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]